Dr Reddys Laboratories (RDY) Interest Coverage Ratio (2009 - 2016)

Dr Reddys Laboratories (RDY) posted quarterly Interest Coverage Ratio of 1.9 for Q4 2016, down 89.13% on a QoQ basis from 17.5 in Q1 2013.

Dr Reddys Laboratories (RDY) Interest Coverage Ratio (2009 - 2016) Analysis & Trends

Dr Reddys Laboratories (RDY) has reported Interest Coverage Ratio for 5 consecutive years, with 1.9 the latest figure, recorded in Q4 2016.

Quarterly Interest Coverage Ratio changed N/A year-over-year to 1.9 in Q4 2016, while the trailing twelve-month figure through Sep 2017 was 9.29 (changed N/A YoY) and the FY2026 annual result came in at 13.48, down 47.19% from the prior year.
Interest Coverage Ratio retreated to 1.9 in Q4 2016 per RDY's latest filing, from 17.5 in the prior quarter.
Over the last five years, Interest Coverage Ratio for RDY reached as high as 68000000.0 in Q4 2012 and fell as low as 1.9 in Q4 2016.
A 3-year average of 22666673.13 and a median of 17.5 in 2013 frame the typical range for Interest Coverage Ratio.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Interest Cover (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn	-
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn	13.44
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn	-2.81
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn	0.18
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn	-0.07
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn	0.33
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn	5.11
10	Dr Reddys Laboratories	9.82 Bn	9.66 Bn	-	-

Download Data